FAVIOLA MARIN: Open Payments
NPI 1598136350 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $126 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 2 | $58 |
| ABBVIE INC. | 2 | $49 |
| Exact Sciences Corporation | 2 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: Cologuard Collection Kit, QULIPTA, ZENPEP, MOUNJARO, REZDIFFRA, UBRELVY, NEXLETOL, ZORYVE.
Industry payments across MO — which companies pay providers there.
